Industry News

How Mapping COVID-19 Could Help Drug Companies

04/14/2020

Excerpt from the article: When the spread of COVID-19 started to affect the University of Connecticut, the state, and the country, Ranjan Srivastava, department head for Chemical and Biomolecular Engineering, knew he had to spring into action. Drawing on his previous work in mathematically modeling how the Hepatitis B virus spreads, Srivastava realized he could…

Read More

UPMC led global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies

04/13/2020

Excerpt from the article: PITTSBURGH, April 9, 2020 – A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine,…

Read More

Ontario Power Generation makes coronavirus face shields

04/09/2020

Excerpt from the article: “DURHAM — Front-line health-care workers dealing with the COVID-19 pandemic are getting a helping hand from Ontario Power Generation and Ontario Tech University in Oshawa. OPG is using 3D printing technology to produce plastic face shields and the company has partnered with Ontario Tech University to fast-track the production of this…

Read More

VCU doctor leading clinical trial on drug to treat COVID-19 encouraged by initial results

04/09/2020

Excerpt from the article: “RICHMOND, Va. (WRIC) — VCU Health is in the middle of conducting clinical trials for an experimental drug that could possibly treat COVID-19. Dr. Arun Sanyal, the doctor leading the trials, told 8News Tuesday that results are encouraging and it’s about improving how a patient feels, functions and survives. Remdesivir, a…

Read More

Hemarina offers its oxygen carrier molecule to fight the COVID-19 pandemic

04/08/2020

Excerpt from the Article: “Hemarina, a French biotech company, could come to the help of doctors fighting the coronavirus. The company has developed a molecule derived from marine worms, which could help people seriously affected by the COVID-19, who do not have access to respirators. The molecule called M101, binds 40 times more oxygen than…

Read More

Providence researchers request FDA approval for COVID-19 vaccine clinical trial

04/08/2020

Excerpt from the article: “PORTLAND, Ore. — Providence researchers in Portland submitted a request to the Food and Drug Administration for the first clinical trial of a viral COVID-19 vaccine. The Earl A. Chiles Research Institute (EACRI) at Providence’s Robert W. Franz Cancer Center is using its knowledge of cancer vaccine immunotherapy to develop a…

Read More

Canada begins clinical trial of experimental COVID-19 treatment using plasma from recovered individuals

04/07/2020

Excerpt from the article: “A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19. The study, which will involve 1,000 patients from across the country, will include at least 40 Canadian hospitals, and is being overseen by doctors from the University of Montreal,…

Read More

First cell treatment to fight the coronavirus awaits FDA approval for clinical trial

04/07/2020

Excerpt from the article: “The Food and Drug Administration is expected to approve the first of a whole new type of weapon to be tested in the international struggle against COVID-19 as the disease continues to sweep across the globe. New Jersey-based therapeutics company Celularity announced that its cancer treatment, CYNK-001, is awaiting “investigational new…

Read More

How To Combine Quality Management With Risk-Based Monitoring In Clinical Trials

04/06/2020

Meaghan Powers, lead consultant, Halloran Consulting Group penned an excellent article on integrating Quality Management with RBM Meaghan tackles a number topics in the 3 Key Steps To Successful Execution. First, a risk assessment must be conducted both pre-study and ongoing during the trial. Second, a well-articulated study protocol should be developed based on factors…

Read More

Color is launching a high-capacity COVID-19 testing lab and will open-source its design and protocols

04/04/2020

Excerpt from the article: “Genomics health technology startup Color is doing its part to address the global COVID-19 pandemic, and has detailed the steps it’s taking to support expansion of testing efforts in a new blog post and letter from CEO Othman Laraki on Tuesday. The efforts include development of a high-throughput lab that can…

Read More